Itraconazol Slavia (Itraconazole)

Itraconazole blocks the fungal enzyme lanosterol 14α‑demethylase, a key step in ergosterol synthesis. By preventing ergosterol formation, the drug disrupts the integrity of the fungal cell membrane, inhibiting growth and leading to cell death while having limited impact on human cells.

The dosage of Itraconazol Slavia is determined by the prescribing healthcare professional based on the specific infection, severity, patient weight, and renal or hepatic function. Patients should follow the exact regimen provided by their clinician and not adjust the dose on their own.

Safety data for itraconazole in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To request Itraconazol Slavia, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Itraconazol Slavia offers broad‑spectrum activity against many dermatophytes, yeasts, and dimorphic fungi, often providing an oral alternative to agents like fluconazole or terbinafine. Its potency against certain systemic mycoses, such as histoplasmosis and blastomycosis, can be superior, though drug‑interaction potential is higher due to CYP3A4 inhibition.

Store Itraconazol Slavia at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, direct sunlight, and excessive heat to maintain stability and potency throughout its shelf life.

Itraconazol Slavia is taken orally, usually with a full glass of water. Depending on the formulation, it may be recommended to take the dose with food to enhance absorption. Patients should follow the specific instructions given by their prescriber regarding timing and any dietary considerations.

The most serious risks include hepatotoxicity, which may present as jaundice or elevated liver enzymes, and congestive heart failure due to fluid retention. Rare but severe skin reactions such as Stevens‑Johnson syndrome can also occur. Prompt medical attention is required if any of these symptoms develop.

Patients with known hypersensitivity to itraconazole or any azole antifungal should avoid the product. Individuals with uncontrolled heart failure, severe liver disease, or those taking contraindicated medications (e.g., strong CYP3A4 inducers) should not use Itraconazol Slavia without careful medical evaluation.